E Fund Management’s Emergent Biosolutions EBS Stock Holding History

E Fund Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,710	Closed	-$88.9K	–	500
2026 Q1	$88.9K	Buy	+10,710	New	+$111K	﹤0.01%	475
2025 Q2	–	Sell	-10,383	Closed	-$50.5K	–	410
2025 Q1	$50.5K	Buy	10,383 +145	+1%	+$1.2K	﹤0.01%	392
2024 Q4	$97.9K	Buy	+10,238	New	+$93.9K	﹤0.01%	379
2023 Q3	–	Sell	-31,274	Closed	-$230K	–	300
2023 Q2	$230K	Buy	31,274 +9,528	+44%	+$88.4K	0.02%	260
2023 Q1	$225K	Sell	21,746 -20	-0.1%	-$242	0.02%	277
2022 Q4	$257K	Buy	21,766 +5,618	+35%	+$86.9K	0.02%	254
2022 Q3	$339K	Buy	16,148 +1,508	+10%	+$42K	0.03%	216
2022 Q2	$454K	Buy	14,640 +7,286	+99%	+$249K	0.04%	160
2022 Q1	$302K	Buy	+7,354	New	+$324K	0.01%	192

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

E Fund Management's EBS Position: Q2 2026 in Review

E Fund Management sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 10,710 shares — an estimated $88.9K sold.

E Fund Management first reported a position in EBS in Q1 2022 and held it in 9 quarters. The position peaked at $454K in Q2 2022. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

E Fund Management reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
E Fund Management sold 10,710 Emergent Biosolutions shares in Q2 2026, an estimated $88.9K.
E Fund Management first reported a position in Emergent Biosolutions in Q1 2022 and held it in 9 quarters.
E Fund Management's Emergent Biosolutions position peaked at $454K in Q2 2022.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.